Epidemiological and clinical features of tumors of the parotid salivary glands in the Republic of Khakassia

Background. According to Russian and international literature, parotid adenoma tumors account for 3% of all tumors in the body, including 2—4% of all head and neck tumors. Objective. To determine the epidemiological characteristics and medical consequences of treating patients with parotid adenomas in the Republic of Khakassia. Material and methods. The study included a retrospective analysis of 113 medical records of patients with parotid adenomas treated in the Maxillofacial and Plastic Surgery (MFS) departments of the G. Ya. Remishevskaya Republican Clinical Hospital (RCH) and the General Oncology Department of the Republican Clinical Oncology Dispensary (RCOD) from 2022 to 2025. Results. A retrospective epidemiological analysis revealed that over a 4-year period, 3.327 patients were treated in specialized hospitals treating maxillofacial pathologies in the Republic of Khakassia. Of these, 113 patients were hospitalized with diseases of the major salivary glands, accounting for 3.3% of the total number of patients treated. According to statistical data, the localization of parotid salivary gland lesions, relative to the side, had a slight predominance of location on the right side (53.9%), and on the left side (46.1%). Conclusion. Epidemiological data, age-specific and topographic data on the prevalence of parotid salivary gland lesions, quantitative indicators of differences in the choice of surgical treatment method, and the incidence of complications were determined.